A significant difference in the pro-coagulant protein tissue factor (TF) was found between both BC patients subgroups (BC I, p<0.05; BC II, p<0.05) and both CC patients’ subgroups (CC I p<0.01; CC II p<0.001) to their HC (Fig 5A). Here, F3 is linked to breast cancer.